Trends & Insights

By Austin Chuang April 10, 2026
Master the regulatory framework, essential qualifications, and organizational duties for a Good Distribution Practice (GDP) Responsible Person.
By Austin Chuang April 10, 2026
A comprehensive guide to maintaining pharmaceutical supply chain integrity, regulatory compliance, and robust quality management systems.
By Austin Chuang April 10, 2026
Navigate European and international GMP regulations for biotechnological products, focusing on process control, virus safety, and inherent variability.
By Austin Chuang April 10, 2026
Explore the mechanisms of stainless steel oxidation, rouging classifications, and actionable lifecycle management strategies to ensure GMP compliance in your pharmaceutical facility.
By Austin Chuang April 10, 2026
Prepare for the EMA's new 3-year work plan including updates to Annex 15, Annex 22, and key GMP chapters.
By Austin Chuang April 10, 2026
An in-depth analysis of Simtra BioPharma's CGMP violations, highlighting risks from equipment dead legs, failed CAPA, and systemic contamination.
By Austin Chuang April 10, 2026
Discover key GMP violations from the recent FDA Warning Letter to OraLabs Inc. Learn why rigorous Root Cause Analysis is critical for compliance.
By Austin Chuang April 10, 2026
An Indian lab faces FDA action for systemic data destruction, backdated records, and inspection obstruction. See how this impacts CGMP compliance.
By Austin Chuang April 10, 2026
Navigate the regulatory shift towards patient-centric quality attributes for autologous cell and gene therapies with expert insights.
By Austin Chuang April 10, 2026
How ignored Performance Qualification (PQ) failures and systemic dead legs in pharmaceutical water systems led to an FDA Warning Letter.